
Majeed Alosail presented the PACMAN-AMI Trial which was a double-blind, placebo-controlled, randomized clinical trial comparing the use of biweekly subcutaneous alirocumab to placebo, in addition to high-intensity statin therapy among patients undergoing percutaneous coronary intervention for acute myocardial…
Read More












